Hype Stories
Will Broadway Financial (USA Stocks:BYFC) dip even more in April?
3 days ago at Macroaxis By Raphi Shpitalnik |
Despite a negative Jensen Alpha of -0.13 and a Total Risk Alpha of -0.44, Broadway Financial Stock still presents a potential upside of 4.3% for investors looking for growth prospects in April. With a mean deviation of 1.65 and a standard deviation of 2.2, the stock's volatility is relatively low, making it a potentially lucrative investment opportunity for those willing to take on the risk.
Main Points
Broadway Financial's average rating from analysts is 'Strong Sell'. We offer trading advice in line with the current expert consensus on Broadway Financial. Continue Reading...- BYFC Broadway Financial
- Latest Latch Launches Door Property Management and Announces the Acquisition of The Broadway Companys Property Management Division
- BYFC 5.51 -0.48
- Low 5.51
- High 5.81
- Volume 13.2 K
- Alpha -0.35
- Beta 0.0569
- Return On Equity 0.0168
- Return On Asset 0.0038
- Profit Margin 0.14 %
- Operating Margin 0.06 %
- Current Valuation 490.68 M
- Shares Outstanding 6.18 M
- Shares Owned By Insiders 22.28 %
- Shares Owned By Institutions 13.88 %
- Number Of Shares Shorted 8.49 K
- Price To Earning 220.00 X
- Price To Book 0.44 X
- Price To Sales 1.73 X
- Revenue 34.05 M
- Gross Profit 33.06 M
- EBITDA 11.46 M
- Net Income 5.71 M
- Cash And Equivalents 280.14 M
- Cash Per Share 3.70 X
- Total Debt 142.34 M
- Debt To Equity 7.73 %
- Book Value Per Share 13.72 X
- Cash Flow From Operations 6.32 M
- Short Ratio 1.51 X
- Earnings Per Share 0.56 X
- Number Of Employees 83
- Beta 0.6
- Market Capitalization 55.58 M
- Total Asset 1.18 B
- Retained Earnings 9.29 M
- Z Score 0.31
- Five Year Return 2.18 %
- Net Asset 1.18 B
- Accumulation Distribution 681.43
- Daily Balance Of Power (1.60)
- Rate Of Daily Change 0.92
- Day Median Price 5.66
- Day Typical Price 5.61
- Price Action Indicator (0.39)
- Period Momentum Indicator (0.48)
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
The world of finance is a stage, and Broadway Financial (BYFC) is ready for its spotlight moment. As a key player in the Banks - Regional industry, Broadway Financial is showing promising signs of becoming a star performer in your investment portfolio. With a Naive Expected Forecast Value of $6.23 and a Valuation Real Value of $6.11, the stock is currently undervalued, trading at a Market Value of $5.88.
over a week ago at Macroaxis By Rifka Kats |
In the world of investing, the adage 'buy low, sell high' is often repeated, and it may just apply to the potential of Effector Therapeutics. A clinical-stage biopharmaceutical company, Effector Therapeutics is making strides in the development of selective translation regulator inhibitors for cancer treatment. Its lead product, Tomivosertib, is currently in phase 2b clinical trials for metastatic non-small cell lung cancer, positioning the company in a pivotal role within the biotechnology industry.
over a week ago at Macroaxis By Raphi Shpitalnik |
Despite a total risk alpha of -0.47 and a recent price percent change of -4.3%, KVH Industries could be the next big investment opportunity for traders. The communication equipment industry player's last price was $4.45, and with a mean deviation of 2.16, it presents a potential for high returns amidst the market's volatility.
Important Highlights
KVH Industries, with a market risk Beta of -0.73, offers potential diversification benefits in a portfolio. As market returns increase, KVH Industries' returns are expected to decrease at a slower rate, suggesting potential outperformance during bear markets.over two weeks ago at Macroaxis By Ellen Johnson |
Minim Inc. (USA Stocks: MINM), a key player in the Communication Equipment industry, has been showing promising signs of a bullish rebound. The company's recent price change of 1.68 and a significant 33.4% price percent change indicate a strong upward momentum. The stock's Jensen Alpha, a measure of the risk-adjusted performance, stands at 1.91, suggesting that the stock has outperformed the market.
over a month ago at Macroaxis By Raphi Shpitalnik |
The asset utilization indicator represents the revenue generated for every dollar of assets that a company currently holds. Rail Vision has an asset utilization ratio of 1.36 percent. This suggests that the company generates $0.0136 for every dollar of assets.
over two months ago at Macroaxis By Vlad Skutelnik |
Every cloud has a silver lining, and for First Financial (USA Stocks: THFF), that silver lining might just be its recent surge in the stock market. The financial services company, which falls under the domestic banks category, has seen a notable upside in its stock value, with a day typical price of $41.25 and a possible upside price of $43.74. Despite the analyst overall consensus being a 'hold', the accumulation distribution of 542.39 and a daily balance of power of 0.625 suggest a positive momentum.
over two months ago at Macroaxis By Ellen Johnson |
Capstar Financial Holdings (NASDAQ: CSTR) is increasingly catching the attention of retail investors, with its stock price showing a promising increase of 2.44% recently. Despite a Total Risk Alpha of -0.16, indicating a potential loss, the company's Sortino Ratio of 0.12 suggests that it has been effectively managing its risky investments. Furthermore, the bank's Potential Upside of 5.38 points towards a promising future for investors.
over two months ago at Macroaxis By Vlad Skutelnik |
As Kaman Corporation (NYSE: KAMN), a key player in the industrials sector and specifically in trading companies & distributors, wraps up its fiscal year in December, there's a buzz in the market that insiders might be boosting confidence in the stock. Despite the analyst overall consensus leaning towards 'Sell', the stock's valuation hype value stands at $46.73, surpassing its market value of $45.05 and real value of $36.85. This suggests a potential overvaluation, but also indicates a strong belief in the company's future performance.
over two months ago at Macroaxis By Raphi Shpitalnik |
Despite a negative Total Risk Alpha of -0.69 and a concerning Sortino Ratio of -0.05, Helen of Troy stock presents a compelling investment opportunity from a hype viewpoint. The stock's potential upside of 4.46 and a Coefficient of Variation standing at 4.1K suggest that there could be significant returns for investors willing to take on the risk. However, potential investors should be aware of the downside variance of 6.68 and the expected shortfall of -1.79.
Main Takeaways
Macroaxis provides investment recommendations for Helen Of Troy to complement and cross-verify the current analyst consensus on Helen Of Troy. Our trade recommendation engine assesses the entity's potential for growth based solely on the investor's current risk tolerance and investment horizon.over two months ago at Macroaxis By Aina Ster |